Several devices for treating the condition have been cleared by the US Food and Drug Administration (FDA), including Insightec’s Exablate Neuro platform that uses focused ultrasound waves to ...

HIFU is FDA-approved for treating uterine fibroids, prostate cancer, and essential tremors, with devices like Insightec's Exablate Neuro leading adoption. A 2024 JAMA Surgery study found that HIFU ...

Several devices for treating the condition have been cleared by the US Food and Drug Administration (FDA), including Insightec’s Exablate Neuro platform that uses focused ultrasound waves to precisely ...

The ExAblate Neuro System, developed by InSightec in Tirat Carmel, Israel, was utilized for performing a unilateral MR-guided focused ultrasound (MRgFUS) thalamotomy targeting the VIM contralateral to ...

Chicago, April 23, 2025 (GLOBE NEWSWIRE) -- The global ultrasound devices market was valued at US$ 9.35 billion in 2024 and is anticipated to reach US$ 14.18 billion by 2033, growing at a CAGR of ...